Alzheimer's disease (AD) represents the leading cause for senile dementia affecting more than 4 million people worldwide. AD patients display a triad of pathological features including brain atrophy caused by neuronal loss, h-amyloid plaque and neurofibrillary tangles. We previously show that Cyclin
✦ LIBER ✦
Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?
✍ Scribed by Bo Su; Xinglong Wang; David Bonda; Gorge Perry; Mark Smith; Xiongwei Zhu
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 228 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0893-7648
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Cdk5, a therapeutic target for Alzheimer
✍
Li-Huei Tsai; Ming-Sum Lee; Jonathan Cruz
📂
Article
📅
2004
🏛
Elsevier Science
🌐
English
⚖ 124 KB
The dentate gyrus neurogenesis: a therap
✍
Yoshitaka Tatebayashi; Moon H. Lee; Liang Li; Khalid Iqbal; Inge Grundke-Iqbal
📂
Article
📅
2003
🏛
Springer-Verlag
🌐
English
⚖ 485 KB
Mitochondrial abnormalities: A primary b
✍
Mark A. Smith; Keisuke Hirai; Akihiko Nunomura; George Perry
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 125 KB
👁 3 views
The most striking feature of Alzheimer's disease (AD) is the number of abnormalities affecting essentially every aspect of brain homeostasis. Recent work suggests that increased oxidative stress that damages lipids, proteins, and nucleic acids and results in the accumulation of redox-active metals m
ChemInform Abstract: β-APP Processing as
✍
D. W. SMITH; B. MUNOZ
📂
Article
📅
2010
🏛
John Wiley and Sons
⚖ 27 KB
👁 1 views
Ectodomain shedding of the receptor for
✍
Ling Zhang; Rolf Postina; Yingqun Wang
📂
Article
📅
2009
🏛
Springer
🌐
English
⚖ 398 KB
ChemInform Abstract: Secretase Targets f
✍
Michael S. Wolfe
📂
Article
📅
2010
🏛
John Wiley and Sons
⚖ 25 KB
👁 2 views